Eagle Pharmaceuticals
EGRX
#10303
Rank
โ‚ฌ9.48 M
Marketcap
0,73ย โ‚ฌ
Share price
0.00%
Change (1 day)
17.86%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚ฌ9.48 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of โ‚ฌ9.48 Million. This makes Eagle Pharmaceuticals the world's 10303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ9.48 M91.14%
2025โ‚ฌ4.96 M-27.52%
2024โ‚ฌ6.84 M-88.85%
2023โ‚ฌ61.44 M-82.68%
2022โ‚ฌ0.35 B-38.92%
2021โ‚ฌ0.58 B17.69%
2020โ‚ฌ0.49 B-32.51%
2019โ‚ฌ0.73 B49.18%
2018โ‚ฌ0.49 B-26.24%
2017โ‚ฌ0.66 B-43.09%
2016โ‚ฌ1.16 B-7.94%
2015โ‚ฌ1.26 B608.84%
2014โ‚ฌ0.17 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚ฌ9.48 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ453.79 B 4,782,838.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.94 B 884,687.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ238.57 B 2,514,390.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ31.38 B 330,715.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ153.25 B 1,615,220.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ801.86 B 8,451,316.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ96.90 B 1,021,242.55%๐Ÿ‡บ๐Ÿ‡ธ USA